ARCHIVES

Don’t Blame FDA For All Problems, Broder Says

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

NIH Study Sections Use New Scoring Procedure

July 3, 1998

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

Young Scientists Get Their Share Of NCI Grants

March 29, 1974

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

Morale, Money Woes Hit MD Anderson

January 18, 2013